Public Private Partnerships Milestones
14.A-14.P
No filters selected
ID
Title
Status
14.A
Public Private Partnerships: Partnerships to accelerate therapy development
Convene an advisory meeting focused on facilitating public-private partnerships aimed at accelerating the development and test of effective therapies for AD treatment and prevention...
Status
Achieved
14.B
Public Private Partnerships: Convene meetings to accelerate drug development
Convene meetings of the working groups for (i) Rapid Data Sharing and Analysis, (ii) Enabling Bidirectional Translation in AD drug development, (iii) Eliminating IP barriers for Target Validation...
Status
Achieved
14.C
Public Private Partnerships: Support early career investigators
Develop partnerships to support novel/disruptive science that would incentivize students and early-career investigators to adopt a collaborative approach...
Status
In Progress
14.D
Public Private Partnerships: Expand the pre-competitive space
Develop partnerships that expand the precompetitive space through clinical proof of concept mechanism to accelerate translational learning...
Status
To Be Initiated
14.E
Public Private Partnerships: Data sharing
Develop a partnership among key stakeholders to implement the sharing of all data and biosamples from preclinical and clinical studies ...
Status
Achieved
14.F
Public Private Partnerships: Consensus nomenclature
Update consensus on AD/ADRD nomenclature necessary to identify target populations for intervention research...
Status
In Progress
14.G
Public Private Partnerships: Eliminating barriers to sharing, integrating, and reuse of data
Convene an advisory meeting of relevant stakeholders to develop a consensus regarding eliminating barriers to sharing, integrating, and reuse of data...
Status
In Progress
14.H
Public Private Partnerships: Improve institutional practices
Alter institutional practices that impede team science and data sharing in academia
Status
In Progress
14.I
Public Private Partnerships: Best practices for biosamples
Develop and disseminate best practices for the collection, processing, and multi-omics molecular profiling of human and animal model biosamples.
Status
In Progress
14.J
Public Private Partnerships: Advance rational drug repositioning and combination therapy
Convene an advisory meeting of experts from the pharmaceutical industry, government, academia, the FDA, and the non-profit sector...
Status
In Progress
14.K
Community Engagement: Facilitate NIH-NGO interactions on ADRD
Establish effective communication between NIH and NGOs
Status
Achieved
14.L
AD/ADRD Nomenclature: Research, clinical practice, and stakeholder working groups
Organize a working group of stakeholders, including health disparities communities, to develop more consistent nomenclature in dementia research and care.
Status
Achieved
14.M
Health Equity: Health disparities task force
Generate an AD/ADRD health disparities task force
Status
Achieved
14.N
AD/ADRD Nomenclature: Standardized research, clinical practice, and stakeholder nomenclature
Integrate and refine recommendations from working groups into standardized, acceptable and accurate nomenclature that works across the spectrum of stakeholders.
Status
In Progress
14.O
Partnerships: NIA/NIH/FDA collaboration
Collaboration to advance biomarkers and therapy development for AD/ADRD
Status
In Progress
14.P
Partnerships: Global data sharing
Large international collaborations aimed at overcoming barriers to sharing of human data
Status
To Be Initiated